03:29

Lebrikizumab for Atopic Dermatitis: 52-Week Efficacy Review with Dr. Raj Chovatiya I Clinical Trial

11:46

Lifesaving But Not Perfect: A Patient's Experience on Dialysis

03:22

What the FDA Approval of Nemolizumab Means for Prurigo Nodularis, with Gil Yosipovitch, MD

13:31

Crisis Point: Psychiatry at a Crossroad After FDA Decision on MDMA-Assisted Therapy

04:05

Noninvasive Testing in MASLD and What AGILE Scoring May Offer

05:54

Impact of the Nasal Epinephrine Spray for Patients with Severe Allergies, with Edwin H. Kim, MD

06:00

Shai Efrati, MD: Hyperbaric Oxygen Therapy as a Promising Treatment for Fibromyalgia

02:44

What Do the New Roflumilast Foam Data Mean for Psoriasis Patients?

07:13

Considerations for Starting, Monitoring Resmetirom Treatment for MASH

06:54

Psychiatrist Shares Experience Prescribing Zuranolone for Postpartum Depression

04:19

Raj Chovatiya, MD, PhD: How Do Approved Eczema Treatments Compare?

08:20

Phase 3 Upadacitinib Trial Shows Promising Results for Giant Cell Arteritis Treatment

11:55

Improving Colorectal Cancer Screening Compliance with Patient Choice

04:02

A Recap of Gene Therapy Programs in Retina with Charles Wykoff, MD, PhD

06:51

HCPLive Five at ASRS 2024

17:28

Crisis Point: Improving Diversity in Dermatology

08:12

Breaking Schizophrenia Stigma: An Interview with Advocate Kody Green | Tips for Clinicians

03:13

Discussing Post-Hoc Data on Ruxolitinib for Nonsegmental Vitiligo, with David Rosmarin, MD

09:56

The Role of Hyperbaric Oxygen Therapy for Treating Fibromyalgia, with Shai Efrati, MD

04:14

Optimizing Cardiovascular, Renal Prognosis in Diabetes with GLP-1, SGLT2 Combination

10:15

Phase 2 Study Shows KP1077 Improves Symptoms in Idiopathic Hypersomnia

03:20

Current Alcohol-Associated Hepatitis Care and What Larsucosterol May Offer

08:03

Ejim Mark, MD, MPH: Zasocitinib Shows Promise as Next-Generation TYK2 Inhibitor for PsA

03:21

Raj Chovatiya, MD, PhD: Discussing the FDA Approval of Roflumilast for Atopic Dermatitis

09:12

Expert Reacts to FDA Committee Meeting Arguments on MDMA for PTSD I Boadie Dunlop, MD Insights

05:06

Robert Bissonnette, MD: Highlighting Recent Findings on Topical Treatments for Atopic Dermatitis

04:06

Unlocking the Potential of ANGPTL3 in Dyslipidemia

13:02

Optimizing Elite Athlete’s Sleep for Peak Performance, with Jesse D. Cook, MS

06:47

Thriving with Arthritis: Health Insights from Diana Girnita, MD, PhD

07:24

HCPLive Five at ADA 2024

21:20

New Insight: A Look at Gildeuretinol (ALK-001) for Stargardt Disease w/ Seemi Khan, MD

01:00

What to Know: Cannabis and Diabetes Adverse Effects

04:00

What to Know About Cannabis Use and Type 1 Diabetes, with Halis Akturk, MD

05:34

Understanding Disparities in the Liver Transplant Evaluation, Referral Process

07:34

Brian LaMoreaux, MD: Defining and Achieving Remission in Gout with Pegloticase

08:09

Novel CSA Treatments with M. Safwan Badr, MD

04:03

David Rosmarin, MD: Futuristic Therapies for Atopic Dermatitis

20:53

Updates and Unmet Needs in Primary Biliary Cholangitis: An HCPLive Special Report

03:48

Signs and Symptoms of Connective Tissue Disease

05:09

Edward V Loftus, Jr, MD: Discussing FDA Approval of Risankizumab (Skyrizi) in Ulcerative Colitis

10:00

Discussing Changes to Atopic Dermatitis Guidelines, with Robert Sidbury, MD, MPH

05:47

Frederic Lavie, MD, PhD: cDAPSA Demonstrates Efficacy in Monitoring Disease Activity in PsA

10:24

Noninvasive Testing, Candidate Biomarkers in AATD-Associated Liver Disease

09:29

Discover Why Eating Early Improves Sleep, Cardiometabolic Health with Josiane Broussard, PhD

08:02

Michael Grandner, PhD, on Treating Sleep-Related Anxiety: Focus on Insomnia, Not Anxiety

08:44

Naim Alkhouri, MD: Resmetirom Has Been a “Game Changer” in MASH Since FDA Approval

03:42

Revolutionizing Cardiovascular Risk: New Treatments and Modifiable Factors

05:00

Therapies in Development for Hidradenitis Suppurativa

04:12

"Prednisone without Side Effects": The JAK Inhibitor Ceiling in Dermatology

08:43

Advancements in Pediatric Psoriasis Treatment, with Lisa Swanson, MD

29:29

New Insight: A Look at the Oculenz with Michael Freeman, CEO of Ocutrx

04:14

The JAK Inhibitor Safety Conversation

04:51

Secukinumab and Bimekizumab for Hidradenitis Suppurativa

04:32

Cindy X. Cai, MD: Impact of Race, Neighborhood on Diabetic Retinopathy Care

03:54

Awaiting FDA Decision on MDMA Assisted Therapy, with Bessel van der Kolk, MD

05:13

Bessel van der Kolk, MD: The Future of MDMA Assisted Therapy in PTSD

07:54

Bessel van der Kolk, MD: What MDMA Assisted Therapy Taught us About PTSD

13:03

Dimitra Skondra, MD, PhD: Protective Effect of Metformin in Geographic Atrophy

10:32

Deepak Sambhara, MD: Impact of CRT on Aflibercept 8 mg Outcomes in DME

07:43

Sean Adrean, MD: Impact of Baseline VA on Aflibercept 8 mg Outcomes in DME